We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Patent Awarded to eGene

Want a FREE PDF version of this news story?

Complete the form below and we will email you a PDF version of "Patent Awarded to eGene"

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.
Read time:

eGene has announced that the US Patent Office has issued a patent (US 6929779) to the company entitled “Optical detection in bio-separation device using axial radiation output.”

According to eGene’s CEO, Dr. Ming S. Liu, “eGene has revolutionized the bioanalysis market by developing a highly affordable, high performance bio-separation instrument that integrates our novel detection technology.”

eGene was also granted a similar patent from the US Patent Office entitled “Optical detection in bio-separation device using a widened detection zone” (US 6529275) in May 2003.

In mid-2004, eGene launched its high performance genetic analyzer (HDA-GT12™) using its cutting-edge multiple channel capillary electrophoresis technology. The company has shipped over 100 units to research laboratories worldwide.

These instruments are being currently used for wide variety of applications including microsatellites, restriction digest DNA, AFLP, RFLP, RNA sample quality check and oligonucleotide quality check.
“Eventually, researchers will be able to use the power of capillary electrophoresis systems for their targeted applications, so any lab can purchase our affordable instrument, put it on the bench top, and perform procedures that take 5 to 10 minutes,” said Monisha Singh, eGene’s Global Marketing Manager.